Cargando…
Citrate for continuous renal replacement therapy: safer, better and cheaper
In a previous issue of Critical Care, Schilder and colleagues report the results of their multicenter trial (Citrate Anticoagulation Versus Systemic Heparinization; CASH) comparing regional anticoagulation with citrate to heparin anticoagulation. They found that citrate was safer, more efficacious a...
Autor principal: | Oudemans-van Straaten, Heleen M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331134/ https://www.ncbi.nlm.nih.gov/pubmed/25673124 http://dx.doi.org/10.1186/s13054-014-0661-3 |
Ejemplares similares
-
Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2012) -
Clinical review: Anticoagulation for continuous renal replacement therapy - heparin or citrate?
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2011) -
In silico imaging clinical trials: cheaper, faster, better, safer, and more scalable
por: Badano, Aldo
Publicado: (2021) -
Clinical review: Patency of the circuit in continuous renal replacement therapy
por: Joannidis, Michael, et al.
Publicado: (2007) -
Citrate anticoagulation for CRRT: don’t always trust the postfilter iCa results!
por: Oudemans-van Straaten, Heleen M., et al.
Publicado: (2015)